Jon Goldsmith, DPM
Foot & Ankle Surgery · Omaha, NENPI 1548225816
Payments from drug & device makers
What this record shows
Conetic Solutions, Inc. accounts for 62.2% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2022 at $1,348 and has fallen 94.8% since, to $70 in 2025. That places this record below the midpoint for foot & ankle surgery clinicians in NE, where the typical reported total is $5,810.
Across 31 payments — averaging $70.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Conetic Solutions, Inc.$1K
- Stryker$377
- Johnson & Johnson$279
- Amgen$29
- Misonix Inc$27
- SPR Therapeutics, Inc$24
- plus $86 from 5 others
What the payments were for
- Food & beverage$97345%
- Education$1,20055%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Conetic Solutions, Inc. | 6 | $1,352 |
| Stryker | 8 | $377 |
| Johnson & Johnson | 9 | $279 |
| Amgen | 1 | $29 |
| Misonix Inc | 1 | $27 |
| SPR Therapeutics, Inc | 1 | $24 |
| Bioventus LLC | 1 | $20 |
| Paratek Pharmaceuticals, Inc. | 1 | $18 |
| Polynovo North America LLC | 1 | $18 |
| Medtronic | 1 | $16 |
| Heraeus Medical, LLC. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ORTHOLOC 3DI CROSSCHECK$170
- Viaflow$170
How this compares
$2,173 in reported general payments places this provider in the 25th percentile of 43 foot & ankle surgery providers in Nebraska.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 39 | $318 |
| Gabapentin | 21 | $182 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 12 | $136 |
| Cephalexin | 12 | $104 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Omaha
- Bradley CoppleOmaha$83K
- Robert GreenhagenOmaha$29K
- Patrick NelsonOmaha$28K
- Jonathan RouseOmaha$20K
- Scott NelsonOmaha$16K
- Jordan SikesOmaha$15K
- Shannon LensingOmaha$11K
- Jorge AmaroOmaha$10K
- Kevin GrosshansOmaha$8K
- Kent DinucciOmaha$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.